Mustang Bio, Inc.
NASDAQ:MBIO
Overview | Financials
Company Name | Mustang Bio, Inc. |
Symbol | MBIO |
Currency | USD |
Price | 0.248 |
Market Cap | 9,024,026 |
Dividend Yield | 0% |
52-week-range | 0.128 - 1.73 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Manuel Litchman M.D. |
Website | https://www.mustangbio.com |
An error occurred while fetching data.
About Mustang Bio, Inc.
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD